About Interferon regulatory factor 8
Interferon regulatory factor 8 (IRF8) is a protein
from Homo sapiens identified by UniProt accession
Q02556, 426 residues long.
MolForge cross-references it against 0 known binders and
664 disease associations.
Target properties
| Protein name | Interferon regulatory factor 8 |
| UniProt accession | Q02556 |
| Gene | IRF8 |
| Organism | Homo sapiens |
| Length | 426 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (664)
Diseases linked to this target (Open Targets).
- monocyte count · score 0.65
- monocyte percentage of leukocytes · score 0.65
- neutrophil count · score 0.51
- neutrophil percentage of leukocytes · score 0.51
- leukocyte count · score 0.49
- granulocyte percentage of myeloid white cells · score 0.48
- chronic lymphocytic leukemia · score 0.47
- eosinophil count · score 0.46
- ulcerative colitis · score 0.45
- rheumatoid arthritis · score 0.44
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q02556-F1 | alphafold | PREDICTED | 74.70 | — |
Amino-acid sequence (426 residues)
MCDRNGGRRL RQWLIEQIDS SMYPGLIWEN EEKSMFRIPW KHAGKQDYNQ EVDASIFKAW AVFKGKFKEG DKAEPATWKT RLRCALNKSP DFEEVTDRSQ LDISEPYKVY RIVPEEEQKC KLGVATAGCV NEVTEMECGR SEIDELIKEP SVDDYMGMIK RSPSPPEACR SQLLPDWWAQ QPSTGVPLVT GYTTYDAHHS AFSQMVISFY YGGKLVGQAT TTCPEGCRLS LSQPGLPGTK LYGPEGLELV RFPPADAIPS ERQRQVTRKL FGHLERGVLL HSSRQGVFVK RLCQGRVFCS GNAVVCKGRP NKLERDEVVQ VFDTSQFFRE LQQFYNSQGR LPDGRVVLCF GEEFPDMAPL RSKLILVQIE QLYVRQLAEE AGKSCGAGSV MQAPEEPPPD QVFRMFPDIC ASHQRSFFRE NQQITV
Explore Interferon regulatory factor 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets